Search results for "SCALES"

showing 10 items of 543 documents

The reliability of the SADS-LA in a family study setting

1991

The joint-rater and test-retest reliability study of two translated versions of the SADS-LA (Schedule for Affective Disorders and Schizophrenia--Lifetime version--modified for the study of anxiety disorders), one in French and the other in German, have been tested in family study settings, in a sample of patients and first-degree relatives. The test-retest reliability study demonstrated that identification of major affective disorders and schizophrenia was performed with sufficient reliability; however, diagnoses of subtypes of major disorders (e.g. bipolar II disorder) and identification of minor disorders was less reliable. The implications of these findings in phenotype identification du…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsGenetic Linkagebehavioral disciplines and activitiesFamily studiesBipolar II disorderPrevalence of mental disordersmedicineHumansPharmacology (medical)Medical diagnosisPsychiatryBiological PsychiatryReliability (statistics)Psychiatric Status Rating ScalesDepressive DisorderReproducibility of ResultsGeneral Medicinemedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaStructured interviewSchizophreniaAnxietyFemaleSchizophrenic Psychologymedicine.symptomPsychologyFollow-Up StudiesClinical psychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

Long-Term Outcome of Cognitive Impairment in Bipolar Disorder

2011

OBJECTIVE: To evaluate the longitudinal course and outcome of cognitive deficits and their clinical correlates in bipolar disorder. METHOD: One hundred thirteen participants (68 patients and 45 healthy controls) were assessed by the means of a neuropsychological battery targeting attention, psychomotor speed, verbal memory, and executive functions at baseline: 68 euthymic outpatients with a DSM-IV diagnosis of bipolar disorder (53 bipolar I and 15 bipolar II) were enrolled at the Bipolar Disorder Unit of the Hospital Clinic of Barcelona. Forty-five patients completed the follow-up. The assessments started in February 1999 and finished in July 2010. The primary outcome of the study was the c…

AdultMalemedicine.medical_specialtyBipolar DisorderPsychometricsPsychometricsNeuropsychological TestsExecutive FunctionmedicineHumansBipolar disorderPsychomotor learningWechsler ScalesNeuropsychologyWechsler Adult Intelligence ScaleCognitionMiddle Agedmedicine.diseaseExecutive functionsPsychiatry and Mental healthDisease ProgressionPhysical therapyFemaleVerbal memoryCognition DisordersPsychologyFollow-Up StudiesClinical psychologyThe Journal of Clinical Psychiatry
researchProduct

[123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects

1997

[123I]Iodobenzamide (IBZM) is an iodine-labeled dopamine receptor ligand and can be used to visualize brain D2 receptors in humans with single photon emission computerized tomography (SPECT). The ratio of striatal IBZM uptake to uptake in frontal cortex (ST/FC ratio) represents a semiquantitative measure of D2 receptor binding in the striatum. Our study sample included six patients treated with haloperidol (3.0-8.0 mg/day orally; one patient with an average of 0.9 mg/day intramuscularly), five patients with benperidol (9.0-15.0 mg/day orally) and nine patients treated with clozapine (200.0-600.0 mg/day orally). Typical neuroleptics (TNs) and atypical neuroleptics (ANs) were significantly di…

AdultMalemedicine.medical_specialtyBipolar DisorderPyrrolidinesNeuroscience (miscellaneous)Benperidolchemistry.chemical_compoundIodobenzamideBasal Ganglia DiseasesDopamineInternal medicineDopamine receptor D2medicineHaloperidolHumansRadiology Nuclear Medicine and imagingChlorpromazineClozapineClozapineAgedNeurologic ExaminationPsychiatric Status Rating ScalesTomography Emission-Computed Single-PhotonDepressive Disorder MajorSchizophrenia ParanoidDose-Response Relationship DrugReceptors Dopamine D2business.industryBenperidolBrainMiddle AgedCorpus StriatumFrontal LobePsychiatry and Mental healthEndocrinologychemistryDopamine receptorBenzamidesDopamine AntagonistsHaloperidolFemalebusinessAntipsychotic Agentsmedicine.drugPsychiatry Research: Neuroimaging
researchProduct

Bipolar disorders and affective temperaments: a national family study testing the "endophenotype" and "subaffective" theses using the TEMPS-A Buenos …

2007

The purpose of this study is to examine the prevalence of affective temperaments between clinically unaffected relatives of bipolar patients and secondarily to investigate the impact of these "subaffective" forms on their quality of life (QoL).The study was performed in seven sites across Argentina. We administered the scales TEMPS-A and Quality of Life Index to a sample of 114 non-ill first degree relatives of bipolar disorder patients ("cases") and 115 comparison subjects without family history of affective illness ("controls"). We used The Mood Disorder Questionnaire to rule out clinical bipolarity.Mean scores on all TEMPS-A subscales were significantly higher in cases, except for hypert…

AdultMalemedicine.medical_specialtyBipolar Disordermedia_common.quotation_subjectArgentinaQuality of lifeSurveys and QuestionnairesmedicinePersonalityHumansInterpersonal RelationsBipolar disorderFirst-degree relativesFamily historyPsychiatryTemperamentmedia_commonPsychiatric Status Rating ScalesMood DisordersMood Disorder QuestionnaireMiddle Agedmedicine.diseaseAnxiety DisordersCyclothymic DisorderIrritable MoodPsychiatry and Mental healthClinical PsychologyCross-Sectional StudiesPhenotypeEndophenotypeCase-Control StudiesQuality of LifeTemperamentFemaleDysthymic DisorderPsychologyJournal of affective disorders
researchProduct

Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

2016

We analyzed the efficacy of functional remediation, in a sample of patients with bipolar disorder who presented with subsyndromal symptoms. From a total sample of 239 patients with bipolar I and II disorder, according to DSM-IV-TR diagnostic criteria, entering a randomized clinical trial, those patients who presented with subsyndromal symptoms were selected based on a method already described by Berk and colleagues was applied. It consists of using the Clinical Global Impression-Bipolar version (CGI-BP) to establish the scores of the Hamilton Depression Rating Scale (HAM-D) and of the Young Mania Rating Scale (YMRS) that correspond with 1 in the CGI-BP. Functional outcome and mood symptoms …

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentYoung Mania Rating Scalelaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRating scalelawmental disordersmedicinePsychoeducationHumansPharmacology (medical)Bipolar disorderBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesPharmacologyAnalysis of VarianceChi-Square DistributionMiddle Agedmedicine.diseaseCognitive Remediation030227 psychiatryPsychotherapyPsychiatry and Mental healthTreatment OutcomeMoodNeurologyPhysical therapyFemaleNeurology (clinical)PsychologyPsychosocial030217 neurology & neurosurgeryFollow-Up StudiesClinical psychologyEuropean Neuropsychopharmacology
researchProduct

Functional remediation for patients with bipolar II disorder: improvement of functioning and subsyndromal symptoms.

2014

Recently, Functional Remediation (FR) has proven to be effective in improving the functional outcome of euthymic bipolar patients. The aim of this study was to test the efficacy of the FR program in a subsample of euthymic bipolar II patients (BPII). A post-hoc analyses were undertaken using data of 53 BPII outpatients who had participated in a multicenter, rater-blind, randomized, controlled trial exploring the efficacy of FR (n=17) as compared with a Psychoeducation group (PSY) (n=19) and a treatment as usual control group (TAU n=17). The primary outcome variable was the functional improvement defined as the mean change in the Functioning Assessment Short Test (FAST) from baseline to endp…

AdultMalemedicine.medical_specialtyBipolar Disordermedicine.medical_treatmentlaw.inventionBipolar II disorderCognitionRandomized controlled triallawInternal medicinePsychoeducationmedicineHumansPharmacology (medical)Single-Blind MethodBipolar disorderBiological PsychiatryPharmacologyPsychiatric Status Rating ScalesCognitive Behavioral Therapymedicine.diseaseCognitive behavioral therapyPsychiatry and Mental healthTreatment OutcomeNeurologyCognitive remediation therapyFemaleNeurology (clinical)medicine.symptomPsychologyNeurocognitiveManiaClinical psychologyEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

The distinction of bipolar II disorder from bipolar I and recurrent unipolar depression: results of a controlled family study.

1993

The aim of the study was to differentiate bipolar II, bipolar I and recurrent unipolar depression by their familial load for affective disorders. Eighty bipolar, 108 unipolar, 80 control subjects and interviewed first-degree relatives were diagnosed according to Research Diagnostic Criteria using the Schedule for Affective Disorders and Schizophrenia – lifetime version. The morbid risks for bipolar I disorder were equivalent in relatives of bipolar I (3.6%) and bipolar II (3.5%) subjects and lower in relatives of unipolar subjects (1.0%). The morbid risks of relatives for bipolar II disorder distinguished bipolar II subjects (6.1%) from bipolar I subjects (1.8%), from unipolar depressives (…

AdultMalemedicine.medical_specialtyBipolar I disorderBipolar DisorderAdolescentResearch Diagnostic Criteriabehavioral disciplines and activitiesDiagnosis DifferentialBipolar II disorderRisk Factorsmental disordersmedicineHumansBipolar disorderPsychiatryDepression (differential diagnoses)AgedAged 80 and overPsychiatric Status Rating ScalesDepressive DisorderSchedule for Affective Disorders and SchizophreniaMiddle Agedmedicine.diseaseControl subjectsPsychiatry and Mental healthFemalesense organsPsychologyClinical psychologyActa psychiatrica Scandinavica
researchProduct

Nonlinear analysis of sleep eeg in depression: Calculation of the largest lyapunov exponent

1995

Conventional sleep analysis according to Rechtschaffen and Kales (1968) has provided meaningful contributions to the understanding of disturbed sleep architecture in depression. However, there is no characteristic alteration of the sleep cycle, which could serve as a highly specific feature for depressive illness. Therefore, we started to investigate nonlinear properties of sleep electroencephalographic (EEG) data in order to elucidate functional alterations other than those obtained from classical sleep analysis. The application of methods from nonlinear dynamical system theory to EEG data has led to the assumption that the EEG can be treated as a deterministic chaotic process. Chaotic sys…

AdultMalemedicine.medical_specialtyChaoticSleep REMPoison controlLyapunov exponentAudiologyElectroencephalographysymbols.namesakemedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryPsychiatric Status Rating ScalesDepressive DisorderSleep Stagesmedicine.diagnostic_testEye movementElectroencephalographyGeneral MedicineMiddle AgedSleep in non-human animalsPsychiatry and Mental healthNonlinear systemsymbolsFemalePsychologyEuropean Archives of Psychiatry and Clinical Neuroscience
researchProduct

The switch from conventional to atypical antipsychotic treatment should not be based exclusively on the presence of cognitive deficits. A pilot study…

2010

Abstract Background Atypical antipsychotics provide better control of the negative and affective symptoms of schizophrenia when compared with conventional neuroleptics; nevertheless, their heightened ability to improve cognitive dysfunction remains a matter of debate. This study aimed to examine the changes in cognition associated with long-term antipsychotic treatment and to evaluate the effect of the type of antipsychotic (conventional versus novel antipsychotic drugs) on cognitive performance over time. Methods In this naturalistic study, we used a comprehensive neuropsychological battery of tests to assess a sample of schizophrenia patients taking either conventional (n = 13) or novel a…

AdultMalemedicine.medical_specialtyCognition disorderslcsh:RC435-571Teràpia cognitivamedicine.drug_classmedicine.medical_treatmentAtypical antipsychoticPilot ProjectsComorbidityCognitive therapyNeuropsychological TestsTrastorns de la cogniciólcsh:PsychiatryResearch articlemedicineHumansVerbal fluency testLongitudinal StudiesAntipsychotic drugsEffects of sleep deprivation on cognitive performancePsychiatryAntipsychoticRetrospective StudiesPsychiatric Status Rating ScalesCognitionExecutive functionsmedicine.diseasePsychiatry and Mental healthTreatment OutcomeSchizophreniaSchizophreniaFemaleSchizophrenic PsychologyAntipsicòticsEsquizofrèniaVerbal memoryCognition DisordersPsychologyAntipsychotic AgentsClinical psychologyBMC Psychiatry
researchProduct

Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neurocognitive performance.

2011

Abstract Purpose To investigate whether symptomatic remission relates to better outcomes in schizophrenia. Methods Seventy-six schizophrenia patients were assessed using measures of cross-sectional symptomatic remission, social functioning, subjective quality of life (QoL), and cognition. Results Most patients (53; 69.7%) were not in remission. Remitted patients presented significantly better social functioning, better self-reported QoL, insight, and lower levels of depressive symptoms. They also showed a non-significant trend for better executive function, processing speed and verbal memory. Conclusions Symptomatic remission may be a good indicator of better clinical status, social functio…

AdultMalemedicine.medical_specialtyCross-sectional studyNeuropsychological TestsStatistics NonparametricQuality of lifeRecurrencemedicineHumansCognitive skillPsychiatryBiological PsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesAnalysis of VarianceCognitionMiddle Agedmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesSchizophreniaQuality of LifeSchizophreniaFemaleSchizophrenic PsychologySelf ReportVerbal memoryPsychologyCognition DisordersNeurocognitiveSocial AdjustmentClinical psychologySchizophrenia research
researchProduct